Pain assessment and its associated factors during insertion of the intrauterine device in Primary Health Care
DOI:
https://doi.org/10.5712/rbmfc17(44)3099Keywords:
Intrauterine device, Pain, Primary health care.Abstract
Introduction: The insertion of the intrauterine device is an expected competence for the general practitioner. However, this method faces many barriers to be inserted in health centers such as the lack of professionals’ training and women’s fear of feeling pain. Objective: To evaluate the intensity of pain during the intrauterine device insertion procedure performed by general practitioners in health centers in the metropolitan region of João Pessoa and its association with sociodemographic factors, clinical aspects of women, and medical training. Methods: This is a cross-sectional and descriptive study, based on data collected from 16 health centers in the cities of Conde, Caaporã, João Pessoa, and Sapé (state of Paraíba, Brazil) from March to October 2019. Data collection was carried out by individual interview with a structured questionnaire and pain was rated by the Visual Analog Scale. Data were analyzed using Mann-Whitney Test and Pearson’s Chi-square Test. Results: The study included 139 women aged between 14 and 47 years, whose mean pain was 5.5 for those who were menstruating and 4.6 for those who were not. Mild pain was present in 20.1%; moderate pain, in 38%; and intense pain, in 31.7%. Hysterometry above 7cm, history of use of anti-inflammatory drugs during menstruation, and dysmenorrhea were more present in those who reported intense pain (p<0.001). Regarding the qualification of the physician who inserts the intrauterine device, there was no statistical significance in the correlation of intense pain with being a resident (p=0.268), time since graduation (p=0.080), or technical difficulty encountered (p=0.065). Conclusions: Therefore, pain was mostly considered as moderate, and IUD insertion is a feasible offer and procedure to be taught and implemented in Primary Health Care.
Downloads
Metrics
References
Singh S, Sedgh G, Hussain R. Unintended pregnancy: worldwide levels, trends and outcomes. Stud Fam Plann 2010;41(4):241-50. https://doi.org/10.1111/j.1728-4465.2010.00250.x DOI: https://doi.org/10.1111/j.1728-4465.2010.00250.x
Prietsch SOM, González-Chica DA, Cesar JA, Mendoza-Sassi RA. Gravidez não planejada no extremo Sul do Brasil: prevalência e fatores associados. Cad Saúde Pública 2011;27(10):1906-16. https://doi.org/ 10.1590/S0102-311X2011001000004 DOI: https://doi.org/10.1590/S0102-311X2011001000004
Brasil. Política nacional de atenção integral à saúde da mulher: princípios e diretrizes/Ministério da Saúde, Secretaria de Atenção à Saúde, Departamento de Ações Programáticas Estratégicas. Brasília: Ministério da Saúde; 2004.
Trussell J. Contraceptive failure in the United States. Contraception 2004;70(2):89-96. https://doi.org/10.1016/j.contraception.2004.03.009 DOI: https://doi.org/10.1016/j.contraception.2004.03.009
Borges ALV, Araújo KS, Santos OA, Gonçalves RFS, Fujimori E, Divino EA. Conhecimento e interesse em usar o dispositivo intrauterino entre mulheres usuárias de unidades de saúde. Rev Latino-Am Enfermagem 2020;28:e3232. https://doi.org/10.1590/1518-8345.3140.3232 DOI: https://doi.org/10.1590/1518-8345.3140.3232
Gonzaga VAS, Borges ALV, Santos AO, Rosa PLFS, Gonçalves RFS. Barreiras organizacionais para disponibilização e inserção do dispositivo intrauterino nos serviços de atenção básica à saúde. Rev Esc Enferm USP 2017;51:e03270. https://doi.org/101590/s1980-220x2016046803270 DOI: https://doi.org/10.1590/s1980-220x2016046803270
Potter J, Rubin SE, Sherman P. Fear of intrauterine contraception among adolescents in New York City. Contraception 2014;89(5):446-50. https://doi.org/10.1016/j.contraception.2014.01.011 DOI: https://doi.org/10.1016/j.contraception.2014.01.011
Wiebe ER. A comparison of the insertion pain associated with three different types of intrauterine device. Obst Gynecol Int J 2014;129(2):172. https://doi.org/10.1016/j.ijgo.2014.11.004 DOI: https://doi.org/10.1016/j.ijgo.2014.11.004
Brasil. Carteira de serviços da Atenção Primária à Saúde (CaSAPS): versão profissionais de saúde e gestores [recurso eletrônico]/Ministério da Saúde, Secretaria de Atenção Primária à Saúde, Departamento de Saúde da Família. Brasília: Ministério da Saúde; 2020.
Dina B, Peipert LJ, Zhao Q, Peipert JF. Anticipated pain as a predictor of discomfort with intrauterine device placement. Am J Obstet Gynecol 2018;218(2):236.e1-9. https://doi.org/10.1016/j.ajog.2017.10.017 DOI: https://doi.org/10.1016/j.ajog.2017.10.017
Callegari LS, Parisi SM, Schwarz EB. Perceptions of intrauterine contraception among women seeking primary care. Contraception 2013;88(2):269-74. https://doi.org/10.1016/j.contraception.2013.02.004 DOI: https://doi.org/10.1016/j.contraception.2013.02.004
Tyler CP, Whiteman MK, Zapata LB, Curtis KM, Hillis SD, Marchbanks PA. Health care provider attitudes and practices related to intrauterine devices for nulliparous women. Obstet Gynecol 2012;119(4):762-71. https://doi.org/10.1097/aog.0b013e31824aca39 DOI: https://doi.org/10.1097/AOG.0b013e31824aca39
Kaislasuo J, Heikinheimo O, Lähteenmäki P, Suhonen S. Predicting painful or difficult intrauterine device insertion in nulligravid women. Obstet Gynecol 2014;124:345-53. https://doi.org/10.1097/AOG.0000000000000362 DOI: https://doi.org/10.1097/AOG.0000000000000362
Miranda A, Almendra R, Feliciano E, Ricardo C, Nápoles S, Nogueira CS. Fatores associados à perceção de ansiedade e dor na colocação do Sistema Intrauterino com Levonorgestrel. Acta Obstet Ginecol Port 2018;12(4):268-6.
Hubacher D. Copper intrauterine device use by nulliparous women: review of side effects. Contraception 2007;75(Suppl 6):S8-11. https://doi.org/10.1016/j.contraception.2006.12.005 DOI: https://doi.org/10.1016/j.contraception.2006.12.005
Allen RH, Carey MS, Raker C, Goyal V, Matteson K. A prospective cohort study of pain with intrauterine device insertion among women with and without vaginal deliveries. J Obstet Gynaecol 2014;34(3):263-7. https://doi.org/10.3109/01443615.2013.868424. DOI: https://doi.org/10.3109/01443615.2013.868424
Harel Z. Dysmenorrhea in adolescents and young adults: from pathophysiology to pharmacological treatments and management strategies. Expert Opin on Pharmacother 2008;9(15):2661-72. https://doi.org/10.1517/14656566.9.15.2661 DOI: https://doi.org/10.1517/14656566.9.15.2661
Vincent K, Warnaby C, Stagg CJ, Moore J, Kennedy S, Tracey I. Dysmenorrhoea is associated with central changes in otherwise healthy women. Pain 2011;152(9):1966-75. https://doi.org/10.1016/j.pain.2011.03.029 DOI: https://doi.org/10.1016/j.pain.2011.03.029
Hubacher D, Reyes V, Lillo S, Zepeda A, Chen PL, Croxatto H. Pain from copper intrauterine device insertion: Randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol 2006;195(5):1272-7. https://doi.org/10.1016/j.ajog.2006.08.022 DOI: https://doi.org/10.1016/j.ajog.2006.08.022
Abbas AM, Ragab E, Abd Ellah NH, Sabra A, Ali SS, Mohamed A, et al. Effect of topical glyceryl trinitrate cream on pain perception during intrauterine device insertion in multiparous women: A randomized double-blinded placebo-controlled study. J Gynecol Obstet Hum Reprod 2019;48:715-8. https://doi.org/10.1016/j.jogoh.2019.03.007 DOI: https://doi.org/10.1016/j.jogoh.2019.03.007
Conti JA, Lerma K, Schneyer R, Hastings CV, Blumenthal PD, Shaw KA. Self-Administered vaginal lidocaine gel for pain management with intrauterine device insertion: a blinded, randomized controlled trial. Am J Obstet Gynecol 2018;1(1):1e1-7. https://doi.org/10.1016/j.ajog.2018.11.1085 DOI: https://doi.org/10.1016/j.ajog.2018.11.1085
Zapata LB, Jatlaoui TC, Marchbanks PA, Curtis KM. Medications to ease intrauterine device insertion: a systematic review. Contraception 2016;94(6):739-59. https://doi.org/10.1016/j.contraception.2016.06.014 DOI: https://doi.org/10.1016/j.contraception.2016.06.014
Allen RH, Bartz D, Grimes DA, Hubacher D, O'Brien P. Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev 2009;(3):CD007373. https://doi.org/10.1002/14651858.CD007373.pub2 DOI: https://doi.org/10.1002/14651858.CD007373.pub2
Davis SA, Braykov NP, Lathrop E, Haddad LB. Familiarity with long-acting reversible contraceptives among obstetrics and gynecology, family medicine, and pediatrics residents: results of a 2015 national survey and implications for contraceptive provision for adolescents. J Pediatr Adolesc Gynecol 2018;31(1):40-4. https://doi.org/10.1016/j.jpag.2017.09.007 DOI: https://doi.org/10.1016/j.jpag.2017.09.007
Gama ALH, Costa GPO, Herculano TB, Cabral RP, Ventura FAMF. Recorrência de gravidez em mulheres jovens que tiveram acesso a contracepção de alta eficácia. Adolesc Saude 2018;15(3):101-10.
Costa GPO, Cabral RP, Herculano TB, Costa GPO. Adolescent pregnancy: high risk of recurrence despite access to intrauterine devices. BMJ Sex Reprod Health 2018;44(2):149-50. https://doi.org/10.1136/bmjsrh-2017-101787 DOI: https://doi.org/10.1136/bmjsrh-2017-101787
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Danyella da Silva Barreto, Maria Eduarda de Melo Pereira do Rêgo, Alexandre José de Melo Neto, Rafael Dias Gonçalves, Ianna Gil de Farias Morais, Gilka Paiva Oliveira Costa
This work is licensed under a Creative Commons Attribution 4.0 International License.
By submitting a manuscript to the RBMFC, authors retain ownership of the copyright in the article, and authorize RBMFC to publish that manuscript under the Creative Commons Attribution 4.0 license and identify itself as the vehicle of its original publication.
